Skip to Content
Merck

Key Documents

View All Documentation

Skip To

EHU021051

Sigma-Aldrich

MISSION® esiRNA

targeting human MYC

Sign Into View Organizational & Contract Pricing

Select a Size

20 μG
RM 741.00
50 μG
RM 1,323.00

RM 741.00

Check Cart for Availability

Select a Size

Change View
20 μG
RM 741.00
50 μG
RM 1,323.00

About This Item

UNSPSC Code:
41105324
NACRES:
NA.51

RM 741.00

Check Cart for Availability
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

description

Powered by Eupheria Biotech

Quality Level

100

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

CAGATCAGCAACAACCGAAAATGCACCAGCCCCAGGTCCTCGGACACCGAGGAGAATGTCAAGAGGCGAACACACAACGTCTTGGAGCGCCAGAGGAGGAACGAGCTAAAACGGAGCTTTTTTGCCCTGCGTGACCAGATCCCGGAGTTGGAAAACAATGAAAAGGCCCCCAAGGTAGTTATCCTTAAAAAAGCCACAGCATACATCCTGTCCGTCCAAGCAGAGGAGCAAAAGCTCATTTCTGAAGAGGACTTGTTGCGGAAACGACGAGAACAGTTGAAACACAAACTTGAACAGCTACGGAACTCTTGTGCGTAAGGAAAAGTAAGGAAAACGATTCCTTCTAACAGAAATGTCCTGAGCAATCACCTATGAACTTGTTTCAAATGCATGATCAAATGCAACCTCACAACCTTGGCTGAG

Ensembl | human accession no.

ENSG00000136997

NCBI accession no.

NM_002467

shipped in

ambient

storage temp.

−20°C

Gene Information

human ... MYC(4609), MYC(4609)

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
EHU051201EHU094591EHU133301
MISSION® esiRNA targeting human MYC

EHU021051

MISSION® esiRNA

MISSION® esiRNA targeting human MYBL1

EHU051201

MISSION® esiRNA

MISSION® esiRNA targeting human MYB

EHU094591

MISSION® esiRNA

MISSION® esiRNA targeting human MYH11

EHU133301

MISSION® esiRNA

Gene Information

human ... MYC(4609), MYC(4609)

Gene Information

human ... MYBL1(4603), MYBL1(4603)

Gene Information

human ... MYB(4602), MYB(4602)

Gene Information

human ... MYH11(4629), MYH11(4629)

product line

MISSION®

product line

MISSION®

product line

MISSION®

product line

MISSION®

esiRNA cDNA target sequence

CAGATCAGCAACAACCGAAAATGCACCAGCCCCAGGTCCTCGGACACCGAGGAGAATGTCAAGAGGCGAACACACAACGTCTTGGAGCGCCAGAGGAGGAACGAGCTAAAACGGAGCTTTTTTGCCCTGCGTGACCAGATCCCGGAGTTGGAAAACAATGAAAAGGCCCCCAAGGTAGTTATCCTTAAAAAAGCCACAGCATACATCCTGTCCGTCCAAGCAGAGGAGCAAAAGCTCATTTCTGAAGAGGACTTGTTGCGGAAACGACGAGAACAGTTGAAACACAAACTTGAACAGCTACGGAACTCTTGTGCGTAAGGAAAAGTAAGGAAAACGATTCCTTCTAACAGAAATGTCCTGAGCAATCACCTATGAACTTGTTTCAAATGCATGATCAAATGCAACCTCACAACCTTGGCTGAG

esiRNA cDNA target sequence

TCCTGGACAGAAGAGGAGGACAGGATCATCTATGAAGCACATAAGCGGTTGGGAAATCGTTGGGCAGAAATTGCCAAACTACTTCCAGGAAGGACTGATAATTCTATCAAAAATCATTGGAATTCTACTATGCGAAGAAAAGTGGAACAGGAGGGCTATTTACAAGATGGAATAAAATCAGAACGATCTTCATCTAAACTTCAACACAAACCTTGTGCAGCTATGGATCATATGCAAACCCAGAATCAGTTTTACATACCTATCCCTGGGTATCAGTATGTGTCACCTGAAGGCAATTGTATAGAACATGTTCAGCCTACTTCTGCCTTTATTCAGCAACCCTTCATTGATGAAGATCCTGATAAGGAAAAGAAAATAAAGGAACTTGAGATGCTTCTTATGTCAGCTGAGAATGAAGTTAGAAGAAAGCGAATTCCATCACAGCCTGGAAG

esiRNA cDNA target sequence

GGGCAGTAGAGCTTGGACAGAAAGAAAAGAAACTTGGTGTTAGGTAATTGACTATGCACTAGTATTTCAGACTTTTTAATTTTATATATATATACATTTTTTTTCCTTCTGCAATACATTTGAAAACTTGTTTGGGAGACTCTGCATTTTTTATTGTGGTTTTTTTGTTATTGTTGGTTTATACAAGCATGCGTTGCACTTCTTTTTTGGGAGATGTGTGTTGTTGATGTTCTATGTTTTGTTTTGAGTGTAGCCTGACTGTTTTATAATTTGGGAGTTCTGCATTTGATCCGCATCCCCTGTGGTTTCTAAGTGTATGGTCTCAGAACTGTTGCATGGATCCTGTGTT

esiRNA cDNA target sequence

AACTTCGACGTCACGGGTTACATCGTGGGAGCCAACATTGAGACCTATCTGCTAGAAAAATCACGGGCAATTCGCCAAGCCAGAGACGAGAGGACATTCCACATCTTTTACTACATGATTGCTGGAGCCAAGGAGAAGATGAGAAGTGACTTGCTTTTGGAGGGCTTCAACAACTACACCTTCCTCTCCAATGGCTTTGTGCCCATCCCAGCAGCCCAGGATGATGAGATGTTCCAGGAAACCGTGGAGGCCATGGCAATCATGGGTTTCAGCGAGGAGGAGCAGCTATCCATATTGAAGGTGGTATCATCGGTCCTGCAGCTTGGAAATATCGTCTTCAAGAAGGAAAGAAACACAGACCAGGCGTCCATGCCAGATAACACAGCTGCTCAGAAAGTTTGCCACCTCATGG

Ensembl | human accession no.

ENSG00000136997

Ensembl | human accession no.

ENSG00000185697

Ensembl | human accession no.

ENSG00000118513

Ensembl | human accession no.

ENSG00000133392

form

lyophilized powder

form

lyophilized powder

form

lyophilized powder

form

lyophilized powder

NCBI accession no.

NM_002467

NCBI accession no.

-

NCBI accession no.

NM_005375

NCBI accession no.

NM_001040113

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

10 - Combustible liquids

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

  • Specification Sheet

    • Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number
    DDV
    SBV
    JXU
    AAQQ
    PTU

    Don't see the Right Version?

    If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

    Search for a COA

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Juanjuan Liu et al.
    Annals of biomedical engineering, 45(6), 1407-1419 (2017-03-30)
    Melanoma is a potentially lethal skin cancer with high mortality rate. Recently, the peptide-mediated transdermal delivery of small interference RNA (siRNA) emerges as a promising strategy to treat melanoma by inducing the apoptosis of tumor cells, but the related theoretical
    Yili Tao et al.
    Scientific reports, 8(1), 14477-14477 (2018-09-29)
    Colorectal cancer (CRC) is among the most frequently occurring cancers worldwide. Baicalin is isolated from the roots of Scutellaria baicalensis and is its dominant flavonoid. Anticancer activity of baicalin has been evaluated in different types of cancers, especially in CRC.
    Feifei Zhang et al.
    EBioMedicine, 44, 311-321 (2019-05-13)
    Gastric cancer (GC) ranks the fifth most common cancer, and chemotherapy is one of the most common treatments for GC. However, chemoresistance limits the effectiveness of chemotherapy and leads to treatment failure. This study aims to investigate the biological effect
    Xuyang Wang et al.
    World journal of gastroenterology, 23(18), 3252-3261 (2017-06-02)
    To determine the role of hepatitis B virus X protein (HBx), HBx in regulating hepatic progenitor cell (HPC)-like features in hepatocellular carcinoma (HCC) and the underlying molecular mechanisms. We used a retrovirus vector to introduce wild type HBx or empty
    Shanshan Bai et al.
    Oncogene, 38(25), 4977-4989 (2019-03-02)
    Increased expression of the full-length androgen receptor (AR-FL) and AR splice variants (AR-Vs) drives the progression of castration-resistant prostate cancer (CRPC). The levels of AR-FL and AR-V transcripts are often tightly correlated in individual CRPC samples, yet our understanding of
    View All Related Papers

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service